Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Rxi Pharmaceuticals Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

23 Jul 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Rxi Pharmaceuticals Corp (RXII-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Jul 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for RXII

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

24 Jul 2016 ValuEngine, Inc. 11 $25.00

Wright Investors Service Comprehensive Report for RXi Pharmaceuticals Corp

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

24 Jul 2016 Wright Reports 59 $75.00

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review Summary RXi Pharmaceuticals Corporation (RXi) is a biotech...

19 Jul 2016 GlobalData 50 $300.00

RXI PHARMACEUTICALS CP (RXII=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

16 Jul 2016 Pechala's Reports 2 $25.00

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review Summary RXi Pharmaceuticals Corporation (RXi), a subsidiar...

15 Jun 2016 GlobalData 48 $300.00

Thomson Reuters Stock Report - Rxi Pharmaceuticals Corp (RXII-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00

RXI PHARMACEUTICALD - SPOTLIGHT ON COSMETIC PRODUCT DEVELOPMENT

RXi Pharmaceuticals (RXi) continues to make solid progress with its development pipeline. We anticipate one of two promising ...

18 Apr 2016 Edison Investment Research 7 $10.00

Wright Investors Service Comprehensive Report for RXi Pharmaceuticals Corp

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

13 Apr 2016 Wright Reports 51 $75.00